CPHI & PMEC China 2026
06/2026 – 06/2026
À Propos de l'Entreprise
- Raison sociale: Liaoning Pharmaceutical Innovation Co., Ltd.
- Pays d'enregistrement: China
- Adresse: No.146 Northeast Great Road,, Dadong District, Shenyang
- Nombre d'employés: 25 - 49
Description:
Liaoning Pharmaceutical Innovation Co., Ltd. is located in the Fine Chemical Industry Development Park of Panjin City, Liaoning Province, covering an area of 2,000 square meters, with its synthesis area equipped with 21 multifunctional reactors and more than 30 auxiliary facilities capable of year-round production. The company operates a research and development center, a production workshop and a GMP production base, serving as a GMP manufacturer of veterinary APIs including Pimobendan, Trilostane, Afoxolaner, Oclacitinib Maleate, Barbital and Phenobarbital.
Activités Commerciales
Services de sous-traitance & d’externalisation
FabricantDistributeur
Classification ATC (Anatomique, Thérapeutique, Chimique)
FabricantDistributeur
Produits/Services Clés
- Produits Pharmaceutiques Vétérinaires & Additifs Alimentaires: Maropitant citrate, Pimobendan, Barbital, Trilostane, FLURALANER, Grapiprant, Oclacitinib Maleate, Afoxolaner, Phenobarbital, Romifidine Hydrochloride, Miltefosine, Atipamezole Hydrochloride, Alfaxalone, Toceranib Phosphate, Menbutone, Sarolaner, Lotilaner, Gleptoferron, Fulvestrant
Nos Produits & Services
Sell · Veterinary Pharmaceuticals & Feed Additives
Sell · Veterinary Pharmaceuticals & Feed Additives
Proofs
Évaluations
(0)
(0)
(0)
(0)
(0)
Commentaires
Filtres :
Trier par :
Aucun commentaire disponible.
Laissez votre note & commentaire